Raras
Buscar doenças, sintomas, genes...
Neoplasia de células epitelioides perivascular
ORPHA:595133CID-10 · D21.9DOENÇA RARA

Uma formação em tecidos moles (como músculos, gordura e vasos sanguíneos) composta por células especiais, chamadas epitelioides, que se desenvolvem ao redor dos vasos sanguíneos. Alguns exemplos incluem angiomiolipoma, tumor de células claras "sugar" do pulmão e linfangioleiomiomatose.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma formação em tecidos moles (como músculos, gordura e vasos sanguíneos) composta por células especiais, chamadas epitelioides, que se desenvolvem ao redor dos vasos sanguíneos. Alguns exemplos incluem angiomiolipoma, tumor de células claras "sugar" do pulmão e linfangioleiomiomatose.

Pesquisas ativas
3 ensaios
70 total registrados no ClinicalTrials.gov
Publicações científicas
91 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ adult, childhood, elderly
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: D21.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫁
Pulmão
6 sintomas
🫘
Rins
5 sintomas
🧠
Neurológico
3 sintomas
🩸
Sangue
3 sintomas
👁️
Olhos
2 sintomas
🫃
Digestivo
2 sintomas

+ 13 sintomas em outras categorias

Características mais comuns

Linfangioleiomiomatose pulmonar
Morfologia anormal da genitália interna feminina
Hidrocefalia
Atrofia óptica
Neoplasia renal
Defeito ventilatório restritivo
36sintomas
Sem dados (36)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 36 características clínicas mais associadas, ordenadas por frequência.

Linfangioleiomiomatose pulmonarPulmonary lymphangiomyomatosis
Morfologia anormal da genitália interna femininaAbnormal morphology of female internal genitalia
HidrocefaliaHydrocephalus
Atrofia ópticaOptic atrophy
Neoplasia renalRenal neoplasm

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico91PubMed
Últimos 10 anos74publicações
Pico202414 papers
Linha do tempo
2026Hoje · 2026🧪 1995Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição.

TSC1HamartinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Non-catalytic component of the TSC-TBC complex, a multiprotein complex that acts as a negative regulator of the canonical mTORC1 complex, an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth (PubMed:12172553, PubMed:12271141, PubMed:12906785, PubMed:15340059, PubMed:24529379, PubMed:28215400). The TSC-TBC complex acts as a GTPase-activating protein (GAP) for the small GTPase RHEB, a

LOCALIZAÇÃO

Lysosome membraneCytoplasm, cytosol

VIAS BIOLÓGICAS (5)
MacroautophagyEnergy dependent regulation of mTOR by LKB1-AMPKTP53 Regulates Metabolic GenesInhibition of TSC complex formation by PKBTBC/RABGAPs
MECANISMO DE DOENÇA

Tuberous sclerosis 1

An autosomal dominant multi-system disorder that affects especially the brain, kidneys, heart, and skin. It is characterized by hamartomas (benign overgrowths predominantly of a cell or tissue type that occurs normally in the organ) and hamartias (developmental abnormalities of tissue combination). Clinical manifestations include epilepsy, learning difficulties, behavioral problems, and skin lesions. Seizures can be intractable and premature death can occur from a variety of disease-associated causes.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
59.5 TPM
Cérebro - Hemisfério cerebelar
57.4 TPM
Nervo tibial
37.5 TPM
Ovário
36.5 TPM
Tireoide
35.7 TPM
OUTRAS DOENÇAS (7)
tuberous sclerosis 1isolated focal cortical dysplasia type IIlymphangioleiomyomatosistuberous sclerosis
HGNC:12362UniProt:Q92574
TSC2TuberinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalytic component of the TSC-TBC complex, a multiprotein complex that acts as a negative regulator of the canonical mTORC1 complex, an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth (PubMed:12172553, PubMed:12271141, PubMed:12842888, PubMed:12906785, PubMed:15340059, PubMed:22819219, PubMed:24529379, PubMed:28215400, PubMed:33436626, PubMed:35772404). Within the TSC-TBC complex

LOCALIZAÇÃO

Lysosome membraneCytoplasm, cytosol

VIAS BIOLÓGICAS (6)
Energy dependent regulation of mTOR by LKB1-AMPKTP53 Regulates Metabolic GenesInhibition of TSC complex formation by PKBTBC/RABGAPsAKT phosphorylates targets in the cytosol
MECANISMO DE DOENÇA

Tuberous sclerosis 2

An autosomal dominant multi-system disorder that affects especially the brain, kidneys, heart, and skin. It is characterized by hamartomas (benign overgrowths predominantly of a cell or tissue type that occurs normally in the organ) and hamartias (developmental abnormalities of tissue combination). Clinical manifestations include epilepsy, learning difficulties, behavioral problems, and skin lesions. Seizures can be intractable and premature death can occur from a variety of disease-associated causes.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
133.2 TPM
Cérebro - Hemisfério cerebelar
103.9 TPM
Pituitária
94.3 TPM
Tireoide
88.0 TPM
Testículo
86.3 TPM
OUTRAS DOENÇAS (9)
lymphangioleiomyomatosistuberous sclerosis 2isolated focal cortical dysplasia type IItuberous sclerosis
HGNC:12363UniProt:P49815

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 FYARRO (SIROLIMUS)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

3,948 variantes patogênicas registradas no ClinVar.

🧬 TSC2: NM_000548.5(TSC2):c.4673A>G (p.Glu1558Gly) ()
🧬 TSC2: NM_000548.5(TSC2):c.1241G>A (p.Cys414Tyr) ()
🧬 TSC2: NM_000548.5(TSC2):c.2T>G (p.Met1Arg) ()
🧬 TSC2: NM_000548.5(TSC2):c.734_735del (p.Arg245fs) ()
🧬 TSC2: NM_000548.5(TSC2):c.1234G>T (p.Glu412Ter) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 23
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Neoplasia de células epitelioides perivascular

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

3 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

70 ensaios clínicos encontrados, 3 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
74 papers (10 anos)
#1

Alternative Lengthening of Telomeres in Malignant Perivascular Epithelioid Cell Neoplasms: Correlation With Molecular Features Including ATRX Gene Mutation Status.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2026 Mar

A subset of perivascular epithelioid cell neoplasms (PEComas) is histologically malignant and at high risk for metastasis, and there is limited literature available on the genetic features of these lesions. In addition to driver alterations in the tuberous sclerosis complex/mammalian target of rapamycin pathway or TFE3 fusions, recurrent ATRX mutations have been identified in malignant PEComas. ATRX mutations have been tightly associated with the alternative lengthening of telomeres (ALT) phenotype in a variety of other tumor types. Whether malignant PEComas-regardless of ATRX mutational status-harbor the ALT phenotype has not been characterized. We conducted immunohistochemistry (IHC), next-generation sequencing (NGS), and telomere-specific fluorescence in situ hybridization (FISH) on a cohort of 32 malignant PEComas to evaluate for the ALT phenotype and to correlate with underlying genomic features. TSC1/2/mTOR/RICTOR mutations or TFE3 translocations were detected in 16 of 31 (52%) cases by NGS. Recurrent ATRX alterations were identified in 10 (32%) cases. Sixteen cases underwent ALT FISH, 8 of which harbored ATRX alterations by NGS and/or ATRX loss based on IHC, and 8 cases without detectable ATRX alterations by NGS or loss based on IHC. Twelve (75%) of these 16 cases demonstrated the ALT phenotype by FISH. All 8 (100%) cases with ATRX mutations were ALT positive by FISH. In 8 (50%) cases without ATRX alterations based on NGS, 4 cases demonstrated ALT by FISH. Of these 4 ALT-positive cases lacking ATRX genomic alterations, IHC revealed ATRX protein loss in 1 case. Overall, ATRX alterations were identified in 75% of ALT-positive tumors. Our study provides the first correlation between ALT and genomic features of malignant PEComas, demonstrating that ATRX alterations invariably predict ALT, but that a subset of tumors without mutations in known ALT suppressor genes also activate ALT. These findings confirm that the association between ATRX alterations and ALT observed in other tumor types applies to PEComas and indicates that in a subset of cases, ALT may be activated by ATRX-independent mechanisms.

#2

Renal epithelioid angiomyolipoma: A multi-institutional, international cohort study with emphasis on clinicopathologic prognostic indicators.

Urologic oncology2026 Feb

Renal angiomyolipoma (AML) is a benign perivascular epithelioid cell neoplasm that is often associated with tuberous sclerosis complex (TSC). Epithelioid AML (eAML), a very rare and potentially malignant variant, can be challenging to radiologically differentiate from benign AML and other renal tumors. Adverse histological features have previously been associated to poorer oncological outcomes. This study aimed to characterize this rare disease entity and validate previously reported adverse prognostic factors. This multicenter, retrospective cohort study analyzed 76 patients diagnosed with eAML between 2001 and 2024 across 15 participating centers. Inclusion criteria were histological diagnosis of eAML with negative cytokeratin markers and positive melanocytic markers. Patients were stratified according to previously described adverse pathological features. A total of 76 patients were studied. Most were female (70%), with a median age of 48 years and, 19 patients had TSC. Median tumor size was 45 mm, with a rate of atypical epithelioid cells >70% in 26 (34.2%) patients. According to the Nese's and Brimo's classifications, 4% and 14% of patients were at high risk, respectively. During a median follow- up of 30-months, 5 (6.7 %) patients developed metastases, and 4 (5.3 %) died. At univariable analysis, the number of adverse pathological risk factors, according to both classifications, was significantly associated with worse metastasis free survival (MFS) and cancer specific survival (CSS). Due to the low number of events, a multivariable analysis was not carried out. eAML is extremely rare, and primarily affects middle-aged women. This cohort validated previously described pathological risk factors for worse prognosis, suggesting that patients with multiple adverse features may require more intensive follow-up.

#3

Perivascular Epithelioid Cell Neoplasm of the Uterus: A Case Report.

The journal of obstetrics and gynaecology research2025 Dec

Perivascular epithelioid cell neoplasms (PEComas) represent a rare category of mesenchymal tumors, with the gastrointestinal and gynecological systems being the most frequently affected sites. A 46-year-old patient was referred to our clinic due to prolonged menstrual bleeding, without additional symptoms. Histopathological analysis of the specimens collected through exploratory curettage demonstrated the presence of uterine PEComa, characterized by positive immunohistochemical markers including HMB-45, TFE3, Cathepsin K, and ER. The patient underwent laparoscopic hysterectomy with bilateral adnexectomy. No recurrence of the disease was observed during the subsequent examinations. This case underscores a common diagnostic pitfall: the absence of a distinct mass on imaging. It highlights that a PEComa can present with only non-specific endometrial thickening, making preoperative diagnosis exceptionally challenging and reliant on histopathology. Laparoscopic surgery in our case provided the patient with quick recovery and a less invasive approach with satisfying results and the absence of recurrent disease during a one-year follow-up period. Future multicenter studies should facilitate a deeper comprehension and undoubtedly lead to a more effective management of a rare and enigmatic condition that is uterine PEComa.

#4

Uterine Broad Ligament Perivascular Epithelioid Cell Tumors (PEComa): A Case Report with 1-Year Follow-Up.

Current medical imaging2025 Oct 15

<p> Introduction: This article presents a case of a patient with a broad ligament perivascular epithelioid cell tumor (PEComa), focusing on the analysis of its imaging features in CT and MRI to enhance understanding and awareness of this rare tumor. </p> <p> Case Presentation: This article reports a case of a 27-year-old married woman who was found to have a pelvic mass two years ago. After detailed examination at our hospital, imaging studies, including enhanced CT and MRI, revealed a cystic-solid lesion in the left adnexal area, with preoperative considerations of ovarian cystadenoma or uterine leiomyoma. She was referred to a specialized obstetrics and gynecology hospital for surgery, and the postoperative pathology was diagnosed as PEComa. She has been undergoing regular follow-up at our hospital post-surgery. One year after the operation, her laboratory tests showed no significant abnormalities, and imaging studies did not reveal any signs of metastasis. </p> <p> Conclusion: Uterine broad ligament PEComa is a rare tumor, and accurate imaging features and classification criteria can aid in improving preoperative diagnosis. A deeper understanding of the clinical and imaging characteristics of this rare disease is significant for enhancing diagnostic accuracy and treatment outcomes. </p>.

#5

A perivascular epithelioid cell neoplasm of the bladder diagnosed after six years: A case report.

Urology case reports2025 Nov

Perivascular epithelioid cell neoplasm (PEComa) is a rare mesenchymal-derived tumor with specific histological and immunohistochemical manifestations. Given the rarity of bladder PEComa, standardized diagnostic and therapeutic protocols have yet to be established. This article presents a case of bladder PEComa that was ultimately diagnosed after a six-year delay and reviews recent studies to improve clinicians' understanding of this tumor and minimize the risk of misdiagnosis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC57 artigos no totalmostrando 73

2026

Alternative Lengthening of Telomeres in Malignant Perivascular Epithelioid Cell Neoplasms: Correlation With Molecular Features Including ATRX Gene Mutation Status.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2025

Perivascular Epithelioid Cell Neoplasm of the Uterus: A Case Report.

The journal of obstetrics and gynaecology research
2026

Renal epithelioid angiomyolipoma: A multi-institutional, international cohort study with emphasis on clinicopathologic prognostic indicators.

Urologic oncology
2025

Uterine Broad Ligament Perivascular Epithelioid Cell Tumors (PEComa): A Case Report with 1-Year Follow-Up.

Current medical imaging
2025

A perivascular epithelioid cell neoplasm of the bladder diagnosed after six years: A case report.

Urology case reports
2025

Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus: A Rare Type of Mesenchymal Tumors and a Management Challenge.

Cancers
2025

Perivascular epithelioid cell neoplasm of the bladder with peritoneal metastasis.

The Canadian journal of urology
2025

TFE3-rearranged ossifying fibromyxoid tumors are uniquely negative for glycoprotein non-metastatic melanoma protein B: A study of 13 TFE3-rearranged mesenchymal tumors.

Human pathology
2024

A case report and literature review: leiomyosarcoma or perivascular epithelioid cell neoplasm?

Frontiers in oncology
2024

Perivascular Epithelial Cell Tumor of the Stomach Diagnosed Preoperatively by Endoscopic Ultrasound-Guided Fine-Needle Aspiration.

Current medical imaging
2024

Sigmoid Colon Angiomyolipoma as a Culprit for Intermittent Constipation and Hematochezia.

ACG case reports journal
2024

Perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder presenting as urinary tract infection in a young woman.

Urology case reports
2024

Accurate prognostic core for localized perivascular epithelioid cell neoplasm.

Cancer
2024

Perivascular epithelioid cell neoplasm of lung.

Thorax
2025

Perivascular epithelioid cell neoplasm (PEComa) harboring TFE3 gene rearrangements in a patient with Lynch syndrome.

Gastroenterologia y hepatologia
2024

Systematic analysis of perivascular epithelioid cell neoplasms in the female reproductive tract: a comprehensive review.

Future oncology (London, England)
2024

Bladder perivascular epithelioid cell neoplasm: Review on clinical features of this rare tumor.

Urology annals
2024

Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).

Medical oncology (Northwood, London, England)
2024

18 F-FAPI for Imaging Metastatic Perivascular Epithelioid Cell Neoplasm.

Clinical nuclear medicine
2024

Clinicopathological features of two ultra-rare cases of malignant perivascular epithelioid cell tumors (PEComas) involving the uterus with recent updates.

Indian journal of pathology &amp; microbiology
2024

Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.

Diagnostic pathology
2024

Hepatic perivascular epithelioid cell neoplasm in a 58-year-old woman.

Polish archives of internal medicine
2023

Hepatic angiomyolipoma, misdiagnosed as hepatocellular carcinoma.

Journal of surgical case reports
2023

Comparison of 18 F-FDG and 68 Ga-FAPI PET/CT in a Patient With Hepatic Perivascular Epithelioid Cell Neoplasm.

Clinical nuclear medicine
2023

Malignant Perivascular Epithelioid Cell Neoplasm of Left Kidney Treated With Targeted Therapy: A Rare Case Report.

Cureus
2023

Angiomyolipoma of Uterine Cervix: Report of a Rare Case.

Cureus
2023

Anti-PD-1 immunotherapy combined with stereotactic body radiation therapy and GM-CSF for the treatment of advanced malignant PEComa: A case report.

Frontiers in oncology
2022

RETROPERITONEAL PERIVASCULAR EPITHELIOID CELL NEOPLASM (PECOMA) RESPONSE TO MTOR KINASE INHIBITION. A CASE REPORT WITH LITERATURE REVIEW.

Georgian medical news
2022

A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex.

Case reports in obstetrics and gynecology
2022

Rapidly Progressive Malignant Pelvic Perivascular Epithelioid Cell Neoplasm (PEComa) Associated with Eggerthella lenta Bloodstream Infection.

Annals of geriatric medicine and research
2022

Primary retroperitoneal PEComa: an incidental finding.

BMJ case reports
2023

Cytopathology of rare gastric mesenchymal neoplasms: A series of 25 cases and review of literature.

Cytopathology : official journal of the British Society for Clinical Cytology
2023

Conjunctival Perivascular Epithelioid Cell Neoplasm With RBM10-TFE3 Fusion Presenting as Recurrent Subconjunctival Hemorrhage.

Ophthalmic plastic and reconstructive surgery
2022

Perivascular epithelioid cell tumour-mimicking retroperitoneal leiomyosarcoma.

BMJ case reports
2022

Diagnosis and treatment of urachal perivascular epithelioid cell neoplasm: A rare case report.

Asian journal of surgery
2022

Differentiating renal epithelioid angiomyolipoma from clear cell carcinoma: using a radiomics model combined with CT imaging characteristics.

Abdominal radiology (New York)
2022

A Rare Case of a Translocation-Associated Perivascular Epithelioid Cell Neoplasm (PEComa).

Case reports in pediatrics
2022

Incidental superficial soft tissue epithelioid angioleiomyoma.

Journal of cutaneous pathology
2022

Nevus, melanoma, or something else? Mesenchymal neoplasms with melanocytic differentiation.

Journal of cutaneous pathology
2022

Single-center Experience in the Diagnosis and Treatment of Hepatic Perivascular Epithelioid Cell Neoplasm.

Journal of clinical and translational hepatology
2022

A review of neoplasms with MITF/MiT family translocations.

Histology and histopathology
2021

Case Report: A Rare Case of a Ventricular Perivascular Epithelioid Cell Tumor With Histologic Characteristics That Resembled a Primary Cardiac Rhabdomyoma.

Frontiers in cardiovascular medicine
2021

Malignant perivascular epithelioid cell neoplasm in the liver: report of a pediatric case.

Surgical case reports
2021

Pericardial Perivascular Epithelioid Cell Neoplasm.

Radiology. Cardiothoracic imaging
2021

Bladder perivascular epithelioid cell neoplasm: The importance of immunohistochemistry in the diagnosis of an unusual neoplasm.

SAGE open medical case reports
2021

A Retrospective Case Study of 13 Uterine Perivascular Epithelioid Cell Neoplasm (PEComa) Patients.

OncoTargets and therapy
2021

Chylous Ascites as a Presentation of Lymphangioleiomyomatosis.

ACG case reports journal
2021

Diagnostic dilemma for an adrenal mass: perivascular epithelioid cell neoplasm versus adrenocortical carcinoma.

ANZ journal of surgery
2020

TFE3 Gene Rearrangement in Perivascular Epithelioid Cell Neoplasm (PEComa) of the Genitourinary Tract.

Clinical genitourinary cancer
2020

Endometrial polyp-like perivascular epithelioid cell neoplasm associated with TFE3 translocation: report of one case.

International journal of clinical and experimental pathology
2020

Hepatic PEcoma: an unusual tumor in an infrequent location.

Cirugia y cirujanos
2020

Primary hepatic perivascular epithelioid cell neoplasm (PEComa) with fever in a 53-year-old man.

Postgraduate medical journal
2020

Malignant Epithelioid Angiomyolipoma of the Kidney (Malignant Perivascular Epithelioid Cell Neoplasm).

Mayo Clinic proceedings
2020

Perivascular Epithelioid Cell Tumor of the Urinary Bladder: A Systematic Review.

International journal of surgical pathology
2020

Renal angiomyolipoma (AML) harboring a missense mutation of TSC2 with copy-neutral loss of heterozygosity (CN-LOH).

Cancer biology &amp; therapy
2020

Parietal Pleura-Based Malignant Perivascular Epithelioid Cell Neoplasm Protruding Into Serous Cavity: A Hitherto Unrecognized Occurrence.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2019

Feasibility of laparoscopic isolated caudate lobe resection for rare hepatic mesenchymal neoplasms.

World journal of clinical cases
2019

Rupture of perivascular epithelioid cell neoplasm at 34 weeks' gestation: A nonendometriosis case of spontaneous hemoperitoneum in pregnancy.

The journal of obstetrics and gynaecology research
2018

[Clinical analysis of hepatic perivascular epithelioid cell neoplasm: a report of eleven cases].

Zhonghua yi xue za zhi
2018

Invagination as Manifestation of a Perivascular Epithelioid Cell Neoplasm (PEComa) of the Colon.

The American journal of gastroenterology
2018

TFE3-Expressing Epithelioid Rich Perivascular Epithelioid Cell Neoplasm (PEComa) of the Bladder with Unusual Benign Course.

Annals of clinical and laboratory science
2018

Primary malignant perivascular epithelioid cell neoplasm (PEComa) of the bone mimicking granular cell tumor in core biopsy: A case report and literature review.

Oncology letters
2017

Hepatic perivascular epithelioid cell neoplasm: A clinical and pathological experience in diagnosis and treatment.

Molecular and clinical oncology
2017

Malignant melanocytic neoplasm of pancreas with liver metastasis: Is it malignant melanoma or clear cell sarcoma?

Indian journal of pathology &amp; microbiology
2017

TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica.

Endocrine pathology
2016

Malignant Perivascular Epithelioid Cell Neoplasm (PEComa) of the Pelvis: A Case Report.

Urology case reports
2016

Hepatic multiple perivascular epithelioid cell neoplasm: A case report and literature review.

Molecular and clinical oncology
2015

[Renal cell carcinoma with t(6;11)(p21.2;q13)/MALAT1-TFEB fusion: a clinical and pathological analysis].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2016

Renal Angiomyolipoma With Sarcoid Granulomas: Report of a Unique Case.

International journal of surgical pathology
2016

Malignant TFE3-rearranged perivascular epithelioid cell neoplasm (PEComa) presenting as a subcutaneous mass.

The British journal of dermatology
2015

Primary retroperitoneal perivascular epithelioid cell neoplasm: A case report.

Oncology letters
2015

Malignant perivascular epithelioid cell neoplasm of the mediastinum and the lung: one case report.

Medicine
2015

Perivascular epithelioid cell neoplasm (PEComa) of the uterus: A systematic review.

International journal of surgery (London, England)

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Neoplasia de células epitelioides perivascular.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Neoplasia de células epitelioides perivascular

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Alternative Lengthening of Telomeres in Malignant Perivascular Epithelioid Cell Neoplasms: Correlation With Molecular Features Including ATRX Gene Mutation Status.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc· 2026· PMID 41577032mais citado
  2. Renal epithelioid angiomyolipoma: A multi-institutional, international cohort study with emphasis on clinicopathologic prognostic indicators.
    Urologic oncology· 2026· PMID 41330802mais citado
  3. Perivascular Epithelioid Cell Neoplasm of the Uterus: A Case Report.
    The journal of obstetrics and gynaecology research· 2025· PMID 41386702mais citado
  4. Uterine Broad Ligament Perivascular Epithelioid Cell Tumors (PEComa): A Case Report with 1-Year Follow-Up.
    Current medical imaging· 2025· PMID 41116272mais citado
  5. A perivascular epithelioid cell neoplasm of the bladder diagnosed after six years: A case report.
    Urology case reports· 2025· PMID 41111482mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:595133(Orphanet)
  2. MONDO:0006359(MONDO)
  3. GARD:22383(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Neoplasia de células epitelioides perivascular
Compêndio · Raras BR

Neoplasia de células epitelioides perivascular

ORPHA:595133 · MONDO:0006359
Prevalência
Unknown
CID-10
D21.9 · Neoplasia benigna do tecido conjuntivo e outros tecidos moles, sem outra especificação
Ensaios
3 ativos
Início
Adolescent, Adult, Childhood, Elderly
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1300127
EuropePMC
Papers 10a
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades